Boston Scientific · 6 hours ago
Process Engineering Intern
Coventry, RI
Internship
Onsite
Intern
$43K/yr - $74K/yrBoston Scientific is a leader in medical science committed to solving health industry challenges. As a Process Engineering Intern, you will play a vital role in advancing the production of medical devices, contributing to transformative projects that enhance manufacturing efficiency and safety.
Health CareMedicalMedical Device
No H1B
Responsibilities
Integrate technology with people to achieve real-world solutions
Collaborate and gain experience from a diverse cross-functional team
Gain better understanding by applying academic knowledge to a real-world problem set
Collaborating on cross-functional projects aimed at process improvement and system upgrades
Develop real world solutions that benefit the long-term efficiency and performance of the site
Contribute to various sustaining efforts to ensure the site continues to be able to operate
Support a site that impacts over 18 million patients per year
Qualification
Required
Must graduate between Fall 2026 – Spring 2027
Currently pursuing an undergraduate bachelor's degree majoring in Mechanical or Industrial Engineering
Must be able to commit to one of the following full internship program periods: May 18th – August 7th OR May 26th – August 14th, 2026
Proficient in Microsoft Excel, Power Bi, and Word
Must be eligible to work in the U.S. without company sponsorship, now or in the future, for employment-based work authorization
Must have reliable transportation to commute to Boston Scientific's Coventry, Rhode Island Location
Preferred
Enthusiasm for learning new technologies and discovering innovative solutions
Experience with Minitab
Knowledge of engineering problem-solving and LEAN tools
Excellent communication and problem-solving skills
Company
Boston Scientific
Boston Scientific is a medical technology company that designs and develops medical devices to diagnose and treat a wide range of condition.
Founded in 1979
10001+ employees
Funding
Current Stage
Public CompanyTotal Funding
$10.02B2025-02-21Post Ipo Debt· $1.58B
2024-02-22Post Ipo Debt· $2.17B
2022-03-04Post Ipo Debt· $3.28B
Leadership Team
Michael Mahoney
Chairman, President & CEO
Daniel J. Brennan
Chief Financial Officer
Recent News
2026-01-22
Company data provided by crunchbase